Lung Allograft Dysfunction
📧 Sign up to get email alerts when something new happens for Lung Allograft Dysfunction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-27Clinical Trial Update: Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1) [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of liposome-encapsulated cyclosporine A for bronchiolitis obliterans after single-…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Assessment of Chronic Lung Allograft Dysfunction Using Single-breath & Multi-breath Hyperpolarized Xenon-129 MRI
A clinical trial update noting the termination of a study evaluating single-breath and multi-breath Hyperpolarized Xenon-129 MRI to assess c…
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: HP 129Xe MRI for Evaluation of CLAD in Lung Transplant Recipients [Phase 2]
Phase 2 study evaluating HP 129Xe MRI for assessment of chronic lung allograft dysfunction in lung transplant recipients has been terminated…
-
CLINICAL_TRIALS trial_result · 2025-07-24Clinical Trial Update: Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2) [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of liposome-encapsulated cyclosporine A for bronchiolitis obliterans after double-lung tr…
-
CLINICAL_TRIALS trial_result · 2025-07-04Clinical Trial Update: Quantitative Parameters of HLA-DQ Antibodies in Lung Transplantation
A completed clinical trial update reporting quantitative parameters of HLA-DQ antibodies in lung transplantation, with relevance to antibody…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-12-06Clinical Trial Update: Trial of Bone-marrow Derived Mesenchymal Stromal Cells (MSC) for New Onset Chronic Lung Allograft Dysfunction [Phase 2]
Phase 2 trial evaluating bone-marrow derived mesenchymal stromal cells for new onset chronic lung allograft dysfunction has been completed.
-
CLINICAL_TRIALS trial_result · 2022-08-17Clinical Trial Update: Studying the Treatment Effect of Pirfenidone in Chronic Lung Allograft Dysfunction (STOP-CLAD) [Phase 2]
Phase 2 trial studying pirfenidone for chronic lung allograft dysfunction in lung transplant recipients was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: European Trial of Pirfenidone in BOS, A European Multi-center Study [Phase 2, Phase 3]
Phase 2/3 European trial of pirfenidone in Bronchiolitis Obliterans related to lung transplant (CLAD) has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-29Clinical Trial Update: Evaluation of Electrical Impedance Tomography for the Diagnosis of Chronic Rejection in Lung Transplants Recipients [NA]
Clinical trial completion evaluating electrical impedance tomography for diagnosing chronic rejection in heart-lung transplant recipients.
-
CLINICAL_TRIALS trial_result · 2017-02-14Clinical Trial Update: Breath Volatile Organic Compounds Patterns of Lung Transplant Patients With Chronic Lung Allograft Dysfunction
A completed clinical trial evaluating breath volatile organic compound patterns in lung transplant patients with chronic lung allograft dysf…